ArticlePloS one2016

Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.

Sarah L Pogue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.